Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v1-EN | |
|---|---|---|
| Language (Changed) | Updated to: French | Was: English |
| Date Updated | 2026-01-28 | 2026-01-28 |
| Drug Identification Number | 02329298 | 02329298 |
| Brand name | TECHNESCAN MAG3 | TECHNESCAN MAG3 |
| Common or Proper name | Kit for the Preparation of Technetium Tc 99m Mertiatide | Kit for the Preparation of Technetium Tc 99m Mertiatide |
| Company Name | CURIUM CANADA INC | CURIUM CANADA INC |
| Ingredients | BETIATIDE | BETIATIDE |
| Strength(s) | 1MG | 1MG |
| Dosage form(s) | POWDER FOR SOLUTION KIT | POWDER FOR SOLUTION KIT |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10ml vial | 10ml vial |
| Additional packaging sizes | ||
| ATC code | V09CA | V09CA |
| ATC description | ||
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2026-01-26 | 2026-01-26 |
| Estimated end date | 2026-02-09 | 2026-02-09 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Technescan MAG3 is currently out of stock. Inventory replenishment is expected by Monday, Feb 9, 2026. We understand the inconvenience this may cause you and apologize for the disruption. | Technescan MAG3 is currently out of stock. Inventory replenishment is expected by Monday, Feb 9, 2026. We understand the inconvenience this may cause you and apologize for the disruption. |
| Health Canada comments |